Medtronic offers EU concessions in $43 bln Covidien deal

BRUSSELS, Nov 11 (Reuters) - U.S. medical device maker Medtronic Inc has offered concessions in a bid to secure European Union regulatory approval for its $43 billion acquisition of Irish rival Covidien Plc, the European Commission said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.